Cargando…
Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
Biologics to TNF family receptors are prime candidates for therapy of immune disease. Whereas recent studies have highlighted a requirement for Fcγ receptors in enabling the activity of CD40, TRAILR, and GITR when engaged by antibodies, other TNFR molecules may be controlled by additional mechanisms...
Autores principales: | Madireddi, Shravan, Eun, So-Young, Lee, Seung-Woo, Nemčovičová, Ivana, Mehta, Amit Kumar, Zajonc, Dirk M., Nishi, Nozomu, Niki, Toshiro, Hirashima, Mitsuomi, Croft, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076583/ https://www.ncbi.nlm.nih.gov/pubmed/24958847 http://dx.doi.org/10.1084/jem.20132687 |
Ejemplares similares
-
Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3(+) Treg Development by Galectin-9 Secretion
por: Oomizu, Souichi, et al.
Publicado: (2012) -
The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
por: Wiersma, Valerie R, et al.
Publicado: (2012) -
Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production
por: Horio, Yuko, et al.
Publicado: (2017) -
Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017) -
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
por: Keryer-Bibens, Cécile, et al.
Publicado: (2006)